Nuvation

Amgen is a biopharmaceutical company that offers research and development services in addition to therapeutic product manufacturing. The company offers laboratory tests, drug development, clinical research and medicinal formulations for the treatment of cancers, rheumatoid arthritis and related diseases. It manufactures a variety of pharmaceutical products, such as skin treatment gels, liquids and tablets. Its brands include Enbrel, EPOGEN, Kepivance, Kineret, NEUPOGEN, Sensipar and Neulasta. The company also offers in-licensing, marketing, promotions and worldwide distribution services. Its areas of therapeutic development operation include oncology, hematology, nephrology, neuroscience, inflammation and metabolic disorders. It employs more than 8,000 individuals. Amgen has one of its offices located in South San Francisco, Calif.

Gilead Sciences Inc., headquartered in Foster City, CA, is a biopharmaceutical company focused on developing innovative medicines in the areas of virology, oncology, and inflammation. The company is recognized as a leading funder of HIV programs in the U.S. and is committed to advancing health equity through scientific innovation. With a robust pipeline of therapies, Gilead aims to address some of the world's most pressing health challenges, including HIV, viral hepatitis, and COVID-19. The company's dedication to patient safety, community engagement, and global health underscores its mission to improve the lives of people and communities worldwide. Generated from the website

Kintara Therapeutics, based in Menlo Park, CA, is a dedicated biopharmaceutical company focused on the development of innovative cancer therapies for patients who have failed or become resistant to current treatment options. With a strong emphasis on academic collaborations and clinical research institutions worldwide, Kintara Therapeutics aims to unlock the promise of biology in the battle against cancer. Their late-stage therapeutic, REM-001, is a second-generation photosensitizer drug that offers significant advantages over previous compounds, targeting solid tumor cancers with unmet medical needs.Generated from the website